UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 142

Sortiert nach

Early Removal of Central Venous Catheter in Patients with Candidemia Does Not Improve Outcome: Analysis of 842 Patients from 2 Randomized Clinical Trials

Clinical infectious diseases, 2010-08, Vol.51 (3), p.295-303

2010

Volltextzugriff (PDF)

Micafungin versus Caspofungin for Treatment of Candidemia and Other Forms of Invasive Candidiasis

Clinical infectious diseases, 2007-10, Vol.45 (7), p.883-893

2007

Volltextzugriff (PDF)

Use of Pharmacokinetic-Pharmacodynamic Analyses To Optimize Therapy with the Systemic Antifungal Micafungin for Invasive Candidiasis or Candidemia

Antimicrobial Agents and Chemotherapy, 2011-05, Vol.55 (5), p.2113-2121

2011

Volltextzugriff (PDF)

Population Pharmacokinetics of Micafungin in Neonates and Young Infants

Antimicrobial Agents and Chemotherapy, 2010-06, Vol.54 (6), p.2633-2637

2010

Volltextzugriff (PDF)

Safety, Tolerability, and Pharmacokinetics of Micafungin (FK463) in Febrile Neutropenic Pediatric Patients

Antimicrobial Agents and Chemotherapy, 2005-08, Vol.49 (8), p.3317-3324

2005

Volltextzugriff (PDF)

Pharmacokinetics, Excretion, and Mass Balance of Liposomal Amphotericin B (AmBisome) and Amphotericin B Deoxycholate in Humans

Antimicrobial Agents and Chemotherapy, 2002-03, Vol.46 (3), p.828-833

2002

Volltextzugriff (PDF)

Population Pharmacokinetics of Micafungin in Pediatric Patients and Implications for Antifungal Dosing

Antimicrobial Agents and Chemotherapy, 2007-10, Vol.51 (10), p.3714-3719

2007

Volltextzugriff (PDF)

Micafungin (FK463), alone or in combination with other systemic antifungal agents, for the treatment of acute invasive aspergillosis

The Journal of infection, 2006-11, Vol.53 (5), p.337-349

2006

Volltextzugriff (PDF)

Pharmacokinetics of an Elevated Dosage of Micafungin in Premature Neonates

The Pediatric infectious disease journal, 2009-05, Vol.28 (5), p.412-415

2009

Volltextzugriff (PDF)

Safety, tolerance, and pharmacokinetics of high-dose liposomal amphotericin B (AmBisome) in patients infected with Aspergillus species and other filamentous fungi: Maximum tolerated dose study

Antimicrobial agents and chemotherapy, 2001-12, Vol.45 (12), p.3487-3496

2001

Volltextzugriff (PDF)

Population pharmacokinetics of micafungin in adult patients

Diagnostic microbiology and infectious disease, 2008-03, Vol.60 (3), p.329-331

2008

Volltextzugriff (PDF)

Plasma Protein Binding of Amphotericin B and Pharmacokinetics of Bound versus Unbound Amphotericin B after Administration of Intravenous Liposomal Amphotericin B (AmBisome) and Amphotericin B Deoxycholate

Antimicrobial Agents and Chemotherapy, 2002-03, Vol.46 (3), p.834-840

2002

Volltextzugriff (PDF)

The Pharmacokinetics and Safety of Micafungin, a Novel Echinocandin, in Premature Infants

The Pediatric infectious disease journal, 2006-12, Vol.25 (12), p.1110-1115

2006

Volltextzugriff (PDF)

Concomitant Cyclosporine and Micafungin Pharmacokinetics in Healthy Volunteers

Journal of clinical pharmacology, 2005-08, Vol.45 (8), p.954-960

2005

Volltextzugriff (PDF)

Concomitant Tacrolimus and Micafungin Pharmacokinetics in Healthy Volunteers

Journal of clinical pharmacology, 2005-09, Vol.45 (9), p.1018-1024

2005

Volltextzugriff (PDF)

Reply to Koh and Luong and to Shaked et al

Clinical infectious diseases, 2010-12, Vol.51 (11), p.1348-1350

2010

Volltextzugriff (PDF)

Triad of Acute Infusion-Related Reactions Associated with Liposomal Amphotericin B: Analysis of Clinical and Epidemiological Characteristics

Clinical infectious diseases, 2003-05, Vol.36 (10), p.1213-1220

2003

Volltextzugriff (PDF)

Safety, Tolerance, and Pharmacokinetics of a Small Unilamellar Liposomal Formulation of Amphotericin B (AmBisome) in Neutropenic Patients

Antimicrobial Agents and Chemotherapy, 1998-09, Vol.42 (9), p.2391-2398

1998

Volltextzugriff (PDF)

Safety, Tolerability, and Pharmacokinetics of Liposomal Amphotericin B in Immunocompromised Pediatric Patients

Antimicrobial agents and chemotherapy, 2017-02, Vol.61 (2)

2017

Volltextzugriff (PDF)

Toxicological Profile and Pharmacokinetics of a Unilamellar Liposomal Vesicle Formulation of Amphotericin B in Rats

Antimicrobial Agents and Chemotherapy, 1998-02, Vol.42 (2), p.263-268

1998

Volltextzugriff (PDF)

The Pharmacokinetics and Pharmacodynamics of Micafungin in Experimental Hematogenous Candida Meningoencephalitis: Implications for Echinocandin Therapy in Neonates

The Journal of infectious diseases, 2008-01, Vol.197 (1), p.163-171

2008

Volltextzugriff (PDF)

Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors

Blood, 2000-09, Vol.96 (6), p.2062-2068

2000

Volltextzugriff (PDF)

Pharmacokinetics of Micafungin in Healthy Volunteers, Volunteers With Moderate Liver Disease, and Volunteers With Renal Dysfunction

Journal of clinical pharmacology, 2005-10, Vol.45 (10), p.1145-1152

2005

Volltextzugriff (PDF)

Pharmacokinetics, Excretion, and Mass Balance of 14C after Administration of 14C-Cholesterol-Labeled AmBisome to Healthy Volunteers

Journal of clinical pharmacology, 2001-09, Vol.41 (9), p.963-971

2001

Volltextzugriff (PDF)

1 – 25 von 142

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(117)
Mit Volltextzugriff
(116)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(142)
Japanisch
(22)

Erscheinungsjahr

n.n

Thema

Science & Technology
(80)
Life Sciences & Biomedicine
(56)
Humans
(52)
Female
(31)
Male
(31)
Biological And Medical Sciences
(27)
Medical Sciences
(26)
Pharmacology. Drug Treatments
(23)
Antifungal Agents
(21)
Adult
(20)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(19)
Microbiology
(17)
Antifungal Agents - Administration & Dosage
(16)
Infectious Diseases
(16)
Middle Aged
(16)
Pharmacology & Pharmacy
(16)
Antifungal Agents - Pharmacokinetics
(15)
Physical Sciences
(15)
Immunology
(13)
Astronomy & Astrophysics
(12)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Early Removal of Central Venous Catheter in Patients with Candidemia Does Not Improve Outcome: Analysis of 842 Patients from 2 Randomized Clinical Trials

Micafungin versus Caspofungin for Treatment of Candidemia and Other Forms of Invasive Candidiasis

Use of Pharmacokinetic-Pharmacodynamic Analyses To Optimize Therapy with the Systemic Antifungal Micafungin for Invasive Candidiasis or Candidemia

Population Pharmacokinetics of Micafungin in Neonates and Young Infants

Safety, Tolerability, and Pharmacokinetics of Micafungin (FK463) in Febrile Neutropenic Pediatric Patients

Pharmacokinetics, Excretion, and Mass Balance of Liposomal Amphotericin B (AmBisome) and Amphotericin B Deoxycholate in Humans

Population Pharmacokinetics of Micafungin in Pediatric Patients and Implications for Antifungal Dosing

Micafungin (FK463), alone or in combination with other systemic antifungal agents, for the treatment of acute invasive aspergillosis

Pharmacokinetics of an Elevated Dosage of Micafungin in Premature Neonates

Safety, tolerance, and pharmacokinetics of high-dose liposomal amphotericin B (AmBisome) in patients infected with Aspergillus species and other filamentous fungi: Maximum tolerated dose study

Population pharmacokinetics of micafungin in adult patients

Plasma Protein Binding of Amphotericin B and Pharmacokinetics of Bound versus Unbound Amphotericin B after Administration of Intravenous Liposomal Amphotericin B (AmBisome) and Amphotericin B Deoxycholate

The Pharmacokinetics and Safety of Micafungin, a Novel Echinocandin, in Premature Infants

Concomitant Cyclosporine and Micafungin Pharmacokinetics in Healthy Volunteers

Concomitant Tacrolimus and Micafungin Pharmacokinetics in Healthy Volunteers

Reply to Koh and Luong and to Shaked et al

Triad of Acute Infusion-Related Reactions Associated with Liposomal Amphotericin B: Analysis of Clinical and Epidemiological Characteristics

Safety, Tolerance, and Pharmacokinetics of a Small Unilamellar Liposomal Formulation of Amphotericin B (AmBisome) in Neutropenic Patients

Safety, Tolerability, and Pharmacokinetics of Liposomal Amphotericin B in Immunocompromised Pediatric Patients

Toxicological Profile and Pharmacokinetics of a Unilamellar Liposomal Vesicle Formulation of Amphotericin B in Rats

The Pharmacokinetics and Pharmacodynamics of Micafungin in Experimental Hematogenous Candida Meningoencephalitis: Implications for Echinocandin Therapy in Neonates

Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors

Pharmacokinetics of Micafungin in Healthy Volunteers, Volunteers With Moderate Liver Disease, and Volunteers With Renal Dysfunction

Phase III study comparing methotrexate and tacrolimus (Prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation

Pharmacokinetics, Excretion, and Mass Balance of 14C after Administration of 14C-Cholesterol-Labeled AmBisome to Healthy Volunteers

Suchergebnisse filtern